Lidamycin Induces Mitophagy in Pancreatic Cancer Cells by Regulating the Expression of Mfn2

Overview

Journal Sci Rep

Specialty Science

Date 2024 Sep 5

PMID 39237684

Authors

Boya Wu

Bing Qi

Liumeng Duan

Jing Chen

Affiliations

Soon will be listed here.

Abstract

Lidamycin (LDM) has been confirmed to have a strong anti-pancreatic cancer effect and can affect the mitochondrial function of pancreatic cancer cells. Mitofusin-2 (Mfn2) is located in the outer membrane of mitochondria, and Mfn2 is currently believed to play a role in cancer inhibition in pancreatic cancer. In order to explore whether the anti-pancreatic cancer effect of LDM is related to Mfn2-mediated mitophagy, Bioinformatics and in vitro cell experiments are used for experimental research. The experimental results demonstrated that Mfn2 is correlated with mitochondrial autophagy in pancreatic cancer. Lidamycin can increase the expression of Mfn2 in pancreatic cancer and affect the process of EMT, affect the level of reactive oxygen species and mitochondrial membrane potential, and increase the expression of mitochondrial autophagy marker proteins BNIP3L and Beclin1. These results demonstrate that Mfn2 affects mitophagy in pancreatic cancer cells by regulating the expression of Mfn2.

References

Eisner V, Picard M, Hajnoczky G . Mitochondrial dynamics in adaptive and maladaptive cellular stress responses. Nat Cell Biol. 2018; 20(7):755-765. PMC: 6716149. DOI: 10.1038/s41556-018-0133-0. View

Brabletz S, Schuhwerk H, Brabletz T, Stemmler M . Dynamic EMT: a multi-tool for tumor progression. EMBO J. 2021; 40(18):e108647. PMC: 8441439. DOI: 10.15252/embj.2021108647. View

Li Y, Dong W, Shan X, Hong H, Liu Y, Liu Y . The anti-tumor effects of Mfn2 in breast cancer are dependent on promoter DNA methylation, the P21 motif and PKA phosphorylation site. Oncol Lett. 2018; 15(5):8011-8018. PMC: 5921267. DOI: 10.3892/ol.2018.8314. View

Nakatogawa H, Suzuki K, Kamada Y, Ohsumi Y . Dynamics and diversity in autophagy mechanisms: lessons from yeast. Nat Rev Mol Cell Biol. 2009; 10(7):458-67. DOI: 10.1038/nrm2708. View

Wood L, Canto M, Jaffee E, Simeone D . Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment. Gastroenterology. 2022; 163(2):386-402.e1. PMC: 9516440. DOI: 10.1053/j.gastro.2022.03.056. View

Panigrahi D, Praharaj P, Bhol C, Mahapatra K, Patra S, Behera B . The emerging, multifaceted role of mitophagy in cancer and cancer therapeutics. Semin Cancer Biol. 2019; 66:45-58. DOI: 10.1016/j.semcancer.2019.07.015. View

Puissant A, Fenouille N, Auberger P . When autophagy meets cancer through p62/SQSTM1. Am J Cancer Res. 2012; 2(4):397-413. PMC: 3410580. View

Miller D, Thorburn A . Autophagy and organelle homeostasis in cancer. Dev Cell. 2021; 56(7):906-918. PMC: 8026727. DOI: 10.1016/j.devcel.2021.02.010. View

Wai T, Langer T . Mitochondrial Dynamics and Metabolic Regulation. Trends Endocrinol Metab. 2016; 27(2):105-117. DOI: 10.1016/j.tem.2015.12.001. View

10.

Yamamoto H, Zhang S, Mizushima N . Autophagy genes in biology and disease. Nat Rev Genet. 2023; 24(6):382-400. PMC: 9838376. DOI: 10.1038/s41576-022-00562-w. View

11.

Pickles S, Vigie P, Youle R . Mitophagy and Quality Control Mechanisms in Mitochondrial Maintenance. Curr Biol. 2018; 28(4):R170-R185. PMC: 7255410. DOI: 10.1016/j.cub.2018.01.004. View

12.

Yoshii S, Mizushima N . Monitoring and Measuring Autophagy. Int J Mol Sci. 2017; 18(9). PMC: 5618514. DOI: 10.3390/ijms18091865. View

13.

Lamark T, Svenning S, Johansen T . Regulation of selective autophagy: the p62/SQSTM1 paradigm. Essays Biochem. 2017; 61(6):609-624. DOI: 10.1042/EBC20170035. View

14.

Rogov V, Dotsch V, Johansen T, Kirkin V . Interactions between autophagy receptors and ubiquitin-like proteins form the molecular basis for selective autophagy. Mol Cell. 2014; 53(2):167-78. DOI: 10.1016/j.molcel.2013.12.014. View

15.

Chen J, Ouyang Z, Zhang S, Zhen Y . Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth. Oncol Rep. 2007; 17(6):1445-51. View

16.

Viale A, Pettazzoni P, Lyssiotis C, Ying H, Sanchez N, Marchesini M . Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature. 2014; 514(7524):628-32. PMC: 4376130. DOI: 10.1038/nature13611. View

17.

Chen H, Zhuo Q, Ye Z, Xu X, Ji S . Organoid model: A new hope for pancreatic cancer treatment?. Biochim Biophys Acta Rev Cancer. 2020; 1875(1):188466. DOI: 10.1016/j.bbcan.2020.188466. View

18.

Kamisawa T, Wood L, Itoi T, Takaori K . Pancreatic cancer. Lancet. 2016; 388(10039):73-85. DOI: 10.1016/S0140-6736(16)00141-0. View

19.

Filadi R, Pendin D, Pizzo P . Mitofusin 2: from functions to disease. Cell Death Dis. 2018; 9(3):330. PMC: 5832425. DOI: 10.1038/s41419-017-0023-6. View

20.

Yang J, Xu R, Wang C, Qiu J, Ren B, You L . Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review. Cancer Commun (Lond). 2021; 41(12):1257-1274. PMC: 8696234. DOI: 10.1002/cac2.12204. View